|
Published by: Kalorama Information
Published: Jan. 1, 1996 - 190 Pages Now 50% off the original sale price of $3,250.
Table of Contents
Chapter One: Executive Summary
- Introduction to Allergy and Asthma
- Allergy
- Asthma
- Drugs Used for the Treatment of Allergy and Asthma
- Treatment of Allergy
- Nonpharmacologic Therapy
- Pharmacologic Therapy
- Antihistamines
- Corticosteroids
- Cromolyn Sodium
- Decongestants
- Immunotherapy
- Treatment of Asthma
- Beta Agonists
- Corticosteroids
- Cromolyn Sodium
- Issues and Trends
- Physician Prescribing Trends
- Trends in Disease Management
- The Market
- Scope and Methodology
- Market Overview
- Size of the Market
- Growth and Future Market
- International Market
- Drugs Used for the Treatment of Allergy
- Antihistamines
- Corticosteroids
- Cromolyn Sodium
- Decongestants
- Drugs Used for the Treatment of Asthma
- Beta Agonists
- Corticosteroids
- Cromolyn Sodium
- Theophylline
Chapter Two: Introduction to Allergy and Asthma
- Allergy
- Epidemiology
- Etiology and Pathology
- Immunologic Mechanisms
- Type I, IgE-Mediated (Immediate) Hypersensitivity
- Type II, Antibody-Mediated (Cytotoxic) Hypersensitivity
- Type III, Immune Complex-Mediated Hypersensitivity
- Type IV, T cell-Mediated (Delayed Hypersensitivity, Cell-Mediated Hypersensitivity)
- Allergens and Antigens
- Contactants
- Ingestants
- Inhalants
- Injectants
- Clinical Picture
- IgE Antibody Tests
- Tests for Immune Complex Allergic Diseases
- Provocation Tests
- Bronchoprovocation Testing
- Conjunctival Provocation Testing
- Nasal Provocation Testing
- Oral Provocation Testing
- Asthma
- Epidemiology
- Etiology
- Pathology
- Clinical Picture
Chapter Three: Drugs Used for the Treatment of Allergy and Asthma
- Treatment of Allergy
- Nonpharmacologic Therapy
- Animal Danders
- Contactants
- Drugs
- Foods
- House Dust and Dust Mites
- Insect Stings
- Mold Spores
- Pollens
- Pharmacologic Therapy
- Antihistamines
- First-Generation, or "Classic", Antihistamines
- Second-Generation Nonsedating Antihistamines
- Corticosteroids
- Cromolyn Sodium
- Decongestants
- Immunotherapy
- Treatment of Asthma
- Beta Agonists
- Corticosteroids
- Cromolyn Sodium
- Theophylline
Chapter Four: Issues and Trends
- Issues Affecting Allergy and Asthma Therapeutics
- Drug Delivery Systems
- Metered-dose Inhalers
- Topical Drugs
- Emergence of Generic Drugs
- Nature of Patient Populations
- Consumer Attitudes
- Profile of Patient Populations
- Allergy
- Asthma
- OTC Status of Allergy and Asthma Drugs
- Products in Development
- Allergy
- Liposome-Encapsulated Allergy Treatment
- Asthma
- Corticotropin-Releasing Factor
- Leukocyte Adhesion Inhibitors
- Leukotriene Inhibitors
- Neuropeptide Blockers
- Tryptase Inhibitors
- Product Interactions
- Allergy
- Recent Drug Approvals
- Allergy
- Physician Prescribing Trends
- Trends in Disease Management
- Trends In Drug Research
- Treatments for Allergies
- Dust Mite
- Gene Therapy
- Monoclonal Antibodies
- Vaccine Strategy
- Treatments for Asthma
- Asthma Gene
Chapter Five: The Market
- Scope and Methodology
- Trends Affecting Market Estimates
- Population
- Market Overview
- Size of the Market
- Growth and Future Market
- International Market
- Drugs Used for the Treatment of Allergy
- Antihistamines
- Corticosteroids
- Cromolyn Sodium
- Decongestants
- Drugs Used for the Treatment of Asthma
- Beta Agonists
- Corticosteroids
- Cromolyn Sodium
- Theophylline
Chapter Six: Company Profiles
- Abbott Laboratories
- History and Lines of Business
- Financial Information
- Allergy and Asthma Drug Products
- Research and Development
- Strategic Alliances
- American Home Products Corporation
- History and Lines of Business
- Financial Information
- Allergy and Asthma Drug Products
- Research and Development
- Corporate Strategies
- Mergers and Acquisitions
- BASF Group
- History and Lines of Business
- Financial Information
- Allergy and Asthma Drug Products
- Corporate Strategies
- Bayer A.G.
- History and Lines of Business
- Financial Information
- Allergy and Asthma Drug Products
- Boehringer Ingelheim Gmbh
- History and Lines of Business
- Financial Information
- Allergy and Asthma Drug Products
- Research and Development
- Boots Pharmaceuticals Inc.
- History and Lines of Business
- Allergy and Asthma Drug Products
- Carter-Wallace, Inc.
- Lines of Business
- Financial Information
- Allergy and Asthma Drug Products
- Research and Development
- Ciba
- History and Lines of Business
- Financial Information
- Allergy and Asthma Drug Products
- Research and Development
- Corporate Strategies
- Fisons Plc
- History and Lines of Business
- Financial Information
- Allergy and Asthma Drug Products
- Research and Development
- Corporate Strategies
- Forest Laboratories, Inc.
- History and Lines of Business
- Financial Information
- Allergy and Asthma Drug Products
- Glaxo Holdings Plc
- History and Lines of Business
- Financial Information
- Allergy and Asthma Drug Products
- Corporate Strategy
- Strategic Alliances
- Johnson & Johnson, Inc.
- Lines of Business
- Financial Information
- Allergy and Asthma Drug Products
- Research and Development
- Marion Merrell Dow Inc.
- History and Lines of Business
- Financial Information
- Allergy and Asthma Drug Products
- Research and Development
- Corporate Strategies
- Mergers and Acquisitions
- Procter & Gamble
- History and Lines of Business
- Financial Information
- Allergy and Asthma Products
- Rhone-Poulenc Rorer Inc.
- History and Lines of Business
- Financial Information
- Allergy and Asthma Drug Products
- Research and Development
- Corporate Strategies
- Strategic Alliances
-
- Sandoz Limited
- Lines of Business
- Financial Information
- Allergy and Asthma Drug Products
- Research and Development
- Corporate Strategies
- Strategic Alliances
- Sanofi S.A.
- History and Lines of Business
- Allergy and Asthma Drug Products
- Schering-Plough Corporation
- History and Lines of Business
- Financial Information
- Allergy and Asthma Drug Products
- Research and Development
- Strategic Alliances
- SmithKline Beecham Plc
- History and Lines Business
- Financial Information
- Allergy and Asthma Drug Products
- Research and Development
- Corporate Strategies
- Strategic Alliances
- 3M
- Lines of Business
- Financial Information
- Allergy and Asthma Drug Products
- Corporate Strategies
- Strategic Alliances
- Warner-Lambert Company
- Lines of Business
- Financial Information
- Allergy and Asthma Drug Products
- Research and Development
- Corporate Strategies
- Wellcome Plc
- History and Lines of Business
- Financial Information
- Allergy and Asthma Drug Products
Appendix A: Key to Abbreviations Used in This Study
Appendix B: Commonly Used Allergy and Asthma Drugs
- Drugs For Allergy
- Antihistamines and Combinations
- Antitussives and Combinations
- Antitussives and Combinations with Narcotics
- Decongestants
- Drugs for Asthma
- Anti-Inflammatory Agents, Nonsteroidal
- Anti-Inflammatory Agents, Steroidal
- Bronchial Dilators
Appendix C: Publications
Appendix D: Agencies and Associations
Appendix E: Companies
AbstractThis report from Kalorama Information analyzes the latest developments and provides historical and forecast data for the major drugs currently in use. Data on market size for 1990 to 2000 are provided for allergy segments--antihistamines, corticosteroids, cromolyn sodium, and decongestants--and for asthma segments--beta agonists, corticosteroids, cromolyn sodium, and throphylline. Other major trends are identified, and pharmaceutical companies competing in the market are profiled.
Get Full Details About This Report >>
|
